arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

MANNATECH INC

MTEX
$4.87 0.00 (0.00%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
20 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
59
Health
Fair
Moderately Bullish
auto_awesome

Analytical Summary

MANNATECH INC demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Profit Margin (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $9.3M
Dividend Yield
Revenue Growth -8.3%
Op. Margin -0.4%
ROIC 90.7%
FCF / Share $-2.27
Trailing P/E
Price / Book
FCF Yield
Debt / Equity -0.53
info Valuation on last close. End-of-day price, Aug 3, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$108.04M
↓ -8.3%
Net Income Profit after all expenses
$-15.21M
↓ -711.0%
Operating Margin Operating profit as % of sales
-0.4%
↓ -132.5% 27th
FCF / Share Free cash flow per share
$-2.27
↓ -317.9%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
19
Returns
100
Financial Health
73
Cash Quality
32

Dividend History

Dividend / share · sourced from SEC filings
$0.20 Latest / share
+0.0% YoY
+8.1% 7-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 72 quarters